Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human WNK2 Antibodies:
anti-Mouse (Murine) WNK2 Antibodies:
anti-Rat (Rattus) WNK2 Antibodies:
Go to our pre-filtered search.
WNK2 promoter methylation and silencing in gliomas is associated with increased JNK (show MAPK8 Antibodies) activation and MMP2 (show MMP2 Antibodies) expression and activity, thus explaining in part tumor cell invasion potential.
Downregulation of WNK2 by promoter hypermethylation occurs early in Pancreatic ductal adenocarcinoma pathogenesis and may support tumor cell growth via the ERK-MAPK (show MAPK1 Antibodies) pathway.
Wnk kinases are positive regulators of canonical Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling.
results validate the WNK2 gene as a recurrent target for epigenetic silencing in glia-derived brain tumours and provide first mechanistic evidence for a tumour-suppressing role of WNK2 that is related to Rac1 signalling and tumour cell invasion and growth
a role for WNK2 in the regulation of CCCs in the mammalian brain, with implications for both cell volume regulation and/or GABAergic signaling.
epigenetic silencing, occasional deletion and point mutation, and functional assessment suggest that aberrations of WNK2 may contribute to unregulated tumor cell growth
WNK2 is involved in the modulation of growth factor-induced cancer cell proliferation through the MEK1 (show MAP2K1 Antibodies)/ERK1/2 (show MAPK1/3 Antibodies) pathway.
WNK2 controls a RhoA (show RHOA Antibodies)-mediated cross-talk mechanism that regulates the efficiency with which MEK1 (show MAP2K1 Antibodies) can activate ERK1/2 (show MAPK1/3 Antibodies) upon growth factor stimulation.
Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.
The protein encoded by this gene is a cytoplasmic serine-threonine kinase that contains cysteine in place of the lysine found at the conserved ATP-binding location in subdomain II of protein kinases. Since this protein does have kinase activity, it is possible that another lysine in the kinase subdomain I can substitute for the missing conserved lysine.
WNK lysine deficient protein kinase 2
, antigen NY-CO-43
, mitogen-activated protein kinase kinase kinase
, protein kinase lysine-deficient 2
, protein kinase with no lysine 2
, protein kinase, lysine deficient 2
, serine/threonine-protein kinase WNK2
, serologically defined colon cancer antigen 43
, kinase deficient protein